~~<i id='5CA93A9A30'><strike id='5CA93A9A30'><tt id='5CA93A9A30'><pre id='5CA93A9A30'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：fashion 2025-09-30 06:09:12 - browse：565

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Eyeing GLP

focus

Wikipedia

leisure time

hotspot

explore

leisure time

AdobeFiveelderlypeoplehavebeenblindedinoneeyebyaseveresideeffectafterreceivinginjectionsofanewlyappr

WSS

Liver decline slowed by off

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

Citing H5N1 threat, CDC urges peak flu monitoring this summer

H5N1 virus can be tracked in retail milk, scientists say

Investigation reveals sickle cell patients pressured into sterilizations

Mega Millions pot grows to $1.25 billion after no winner

focus

hotspot

focus

Jerome Adams on the need for new antivirals for Covid

Reports of telehealth's death have been greatly exaggerated

United colonoscopy coverage change 'may cost lives,' doctors say

What to expect as Trump is arraigned on his Jan 6. indictment

ChatGPT in medicine: STAT answers readers' burning questions

Biogen joins immunology wave with $1.15 billion acquisition of HI

Wildfire smoke exposes gaps in outdoor worker protections

ASCO eve: Let’s set the table for this year's meeting

Tori Bowie and the unacceptable rates of Black maternal death

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Wikipedia

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

New safety details link Apellis eye drug to rare cases of blindness

Adults seen as increasingly susceptible to measles

Investigation reveals sickle cell patients pressured into sterilizations

No plane should take off without an EpiPen onboard

Adults seen as increasingly susceptible to measles

leisure time

hotspot

explore

leisure time